GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CSL CSL.AX · AUD

Health Care · Biotechnology · ASX · 🇦🇺 Australia

Compare

200.77

-0.63%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

CSL — daily ASX:CSL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View CSL on TradingView ↗
Market value
A$96.15bn
Last close × shares
Volume
893.4k
Shares, 9 Nov 2026
Dividend yield
2.08%

About CSL

Its shares trade on ASX under the ticker CSL.AX. It has been listed since 8 June 1994. In the fiscal year to 30 June 2026, it reported revenue of $16.04bn and a net loss of $2.64bn. At that date it held total assets of $33.63bn and shareholders' equity of $14.79bn.

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria. The company offers treatments for people who are living with conditions in the immunology and neurology; haematology and thrombosis; cardiovascular and metabolic; respiratory, and transplant therapeutic areas. Its segment includes CSL Behring and Seqirus. CSL Behring segment manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products.

Figures and description from our data supplier, not checked against the company's own report.

More about CSL →

Latest on CSL

Our reporting

Next results

9 Feb 2027

Due on 9 Feb 2027. Analysts expect earnings of 5.75 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is CSL's ticker?

CSL trades as CSL.AX on ASX, under ISIN AU000000CSL8.

What was CSL's last closing price?

200.77 on 9 Nov 2026. The figure is in AUD and is never converted.

When does CSL next report results?

Results are expected on 9 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.